DE68917729D1 - Reinigung und verabreichung von dns-reparatur-enzymen. - Google Patents

Reinigung und verabreichung von dns-reparatur-enzymen.

Info

Publication number
DE68917729D1
DE68917729D1 DE68917729T DE68917729T DE68917729D1 DE 68917729 D1 DE68917729 D1 DE 68917729D1 DE 68917729 T DE68917729 T DE 68917729T DE 68917729 T DE68917729 T DE 68917729T DE 68917729 D1 DE68917729 D1 DE 68917729D1
Authority
DE
Germany
Prior art keywords
administration
cleaning
dna repair
repair enzymes
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68917729T
Other languages
English (en)
Other versions
DE68917729T2 (de
Inventor
Daniel Yarosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Genetics Inc
Original Assignee
Applied Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Genetics Inc filed Critical Applied Genetics Inc
Application granted granted Critical
Publication of DE68917729D1 publication Critical patent/DE68917729D1/de
Publication of DE68917729T2 publication Critical patent/DE68917729T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE68917729T 1988-07-06 1989-06-27 Reinigung und verabreichung von dns-reparatur-enzymen. Expired - Lifetime DE68917729T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/215,566 US5077211A (en) 1988-07-06 1988-07-06 Purification and administration of dna repair enzymes
PCT/US1989/002873 WO1990000598A1 (en) 1988-07-06 1989-06-27 Purification and administration of dna repair enzymes

Publications (2)

Publication Number Publication Date
DE68917729D1 true DE68917729D1 (de) 1994-09-29
DE68917729T2 DE68917729T2 (de) 1995-04-06

Family

ID=22803479

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917729T Expired - Lifetime DE68917729T2 (de) 1988-07-06 1989-06-27 Reinigung und verabreichung von dns-reparatur-enzymen.

Country Status (8)

Country Link
US (2) US5077211A (de)
EP (1) EP0423214B1 (de)
JP (2) JP3292473B2 (de)
AU (2) AU634970B2 (de)
DE (1) DE68917729T2 (de)
IL (1) IL90880A (de)
WO (1) WO1990000598A1 (de)
ZA (1) ZA894971B (de)

Families Citing this family (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190762A (en) * 1988-07-06 1993-03-02 Applied Genetics, Inc. Method of administering proteins to living skin cells
US5077211A (en) * 1988-07-06 1991-12-31 Applied Genetics, Inc. Purification and administration of dna repair enzymes
US5272079A (en) * 1988-07-06 1993-12-21 Applied Genetics, Inc. Purification and administration of DNA repair enzymes
US5556750A (en) * 1989-05-12 1996-09-17 Duke University Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems
US6372249B1 (en) * 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
US6989242B1 (en) 1992-02-26 2006-01-24 The General Hospital Coporation Car receptors and related molecules and methods
US6733776B1 (en) 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
GB9208339D0 (en) * 1992-04-15 1992-06-03 Unilever Plc Treatment composition
EP0642333B1 (de) * 1992-04-22 1998-06-24 Molecular Rx., Inc. Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase
US5279823A (en) 1992-06-08 1994-01-18 Genentech, Inc. Purified forms of DNASE
US5302389A (en) * 1992-08-17 1994-04-12 Board Of Regents, The University Of Texas System Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease
US6461851B1 (en) 1992-11-19 2002-10-08 Anticancer, Inc. High expression modules containing two or more tandem copies of a methioninase encoding sequence
US5352458A (en) * 1992-12-21 1994-10-04 Applied Genetics Inc. Tanning method using DNA repair liposomes
US5631237A (en) * 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
CA2153780C (en) * 1993-01-15 2004-04-13 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
WO1994017781A1 (en) * 1993-02-03 1994-08-18 Trustees Of Boston University Endonuclease-enhanced tanning
ATE209887T1 (de) * 1993-04-02 2001-12-15 Anticancer Inc Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
US7094766B1 (en) 1995-06-06 2006-08-22 Trustees Of Boston University Use of locally applied DNA fragments
US6147056A (en) * 1995-06-06 2000-11-14 Trustees Of Boston University Use of locally applied DNA fragments
US20030032610A1 (en) * 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US5876995A (en) 1996-02-06 1999-03-02 Bryan; Bruce Bioluminescent novelty items
US6247995B1 (en) 1996-02-06 2001-06-19 Bruce Bryan Bioluminescent novelty items
US6602526B2 (en) 1996-02-23 2003-08-05 Medical Doctors Research Institute Oral compositions containing lotus
US5925348A (en) * 1996-02-23 1999-07-20 Medical Doctor's Research Institute, Inc. Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin
CZ310798A3 (cs) * 1996-03-28 1999-02-17 Trustees Of Boston University Způsob tlumení aktivace tyrosinasy, upravování pigmentace a identifikace látky, látka zesilující fosforylaci tyrosinasy, látka tlumící fosforylaci tyrosinasy, použití činidla tlumícího fosforylaci tyrosinasy, použití peptidu a použití DNA
US6416960B1 (en) 1996-08-08 2002-07-09 Prolume, Ltd. Detection and visualization of neoplastic tissues and other tissues
ATE290205T1 (de) 1996-12-12 2005-03-15 Prolume Ltd Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
US6319507B1 (en) 1997-05-02 2001-11-20 Kobo Products, Inc. Agar gel bead composition and method
US5961990A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Cosmetic particulate gel delivery system and method of preparing complex gel particles
US6375980B1 (en) * 1998-01-08 2002-04-23 Research Development Foundation Stabilization of lipid:DNA formulations during nebulization
EP1925320A3 (de) 1998-03-27 2008-09-03 Prolume, Ltd. Luciferasen, fluoreszierende Proteine, Nukleinsäuren zur Kodierung der Luciferasen und der fluoreszierenden Proteine sowie deren Verwendung zur Diagnose, zum Screening mit hohem Durchsatz und zur Behandlung neuartiger Probleme
US7060455B1 (en) 1998-06-08 2006-06-13 Emory University Broad specificity DNA damage endonuclease
WO1999063828A1 (en) 1998-06-08 1999-12-16 Emory University Broad specificity dna damage endonuclease
EP1274410A2 (de) 2000-03-31 2003-01-15 Trustees Of Boston University Verwendung von lokal aplizierten dna-fragmenten
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
US20030211970A1 (en) * 2001-06-01 2003-11-13 Samuel Nochumson Processing of plasmid-containing fluids
WO2003027238A2 (en) * 2001-09-24 2003-04-03 Applied Genetics Incorporated Dermatics Stabilization of t4 endonuclease v
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7858117B2 (en) * 2002-02-21 2010-12-28 Novosom Ag Amphoteric liposomes and their use
US7758878B2 (en) 2003-10-10 2010-07-20 Access Business Group International Llc Cosmetic treatment system and methods
WO2005034891A2 (en) * 2003-10-10 2005-04-21 Access Business Group International Llc. Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme
RU2006144817A (ru) 2004-05-19 2008-06-27 Трастиз Оф Бостон Юниверсити (Us) Модуляция wrn-опосредованной теломера-инициированной клеточной передачи сигнала
NL1027479C2 (nl) * 2004-10-21 2006-05-01 Synvolux Ip B V Bescherming van biologisch actieve moleculen met behulp van amphifielen.
PL1835922T3 (pl) * 2004-12-22 2009-10-30 Merck Serono Sa Terapia skojarzona stwardnienia rozsianego
EP1904643B1 (de) * 2005-07-01 2013-10-09 Applied Genetics Incorporated Dermatics Herstellung von cpd-glycosylasen
US20080088046A1 (en) * 2006-10-13 2008-04-17 Steffen Panzner Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome
AU2006291429B2 (en) * 2005-09-15 2013-04-04 Biontech Delivery Technologies Gmbh Improvements in or relating to amphoteric liposomes
WO2007040541A1 (en) * 2005-09-27 2007-04-12 Emory University Re-engineered uv damage endonuclease, compositions and methods
KR100809404B1 (ko) * 2005-12-28 2008-03-05 (주)스피어테크 리포좀화 시킨 나노용매를 함유하는 경피흡수 점착시트형 화장료 조성물 및 제조방법
WO2007095175A2 (en) * 2006-02-15 2007-08-23 Massachusetts Institute Of Technology Thermo-responsive materials
DE102006015271A1 (de) * 2006-04-01 2007-10-11 Lohmann & Rauscher Gmbh & Co. Kg Biguanidhaltige Liposomen
US8007790B2 (en) 2006-04-03 2011-08-30 Stowers Institute For Medical Research Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases
WO2009047006A2 (en) * 2007-10-12 2009-04-16 Novosom Ag Amphoteric liposomes comprising neutral lipids
EP2462924A3 (de) * 2006-10-13 2013-01-23 Marina Biotech, Inc. Verbesserungen an oder im Zusammenhang mit amphoteren Liposomen
US20080207711A1 (en) * 2007-02-28 2008-08-28 Rong Li Method for treating an ID2-related disorder
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US8193155B2 (en) 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US8703161B2 (en) * 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
CA2702710C (en) 2007-10-16 2013-05-07 Repros Therapeutics, Inc. Trans-clomiphene for metabolic syndrome
US8101606B2 (en) * 2007-11-12 2012-01-24 Washington University Neurofibromin pathway modulators
AU2009209031A1 (en) * 2008-01-30 2009-08-06 Oregon Health & Science University DNA repair polypeptides and methods of delivery and use
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
US20100273203A1 (en) * 2009-04-23 2010-10-28 Board Of Trustees Of The University Of Arkansas Methods and compositions for detecting metabolites
US8765156B2 (en) 2009-05-04 2014-07-01 Elc Management Llc Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
WO2010129313A2 (en) 2009-05-04 2010-11-11 Elc Management Llc Cosmetic compositions comprising cyanodiphenylacrylates
JP2009203240A (ja) * 2009-06-15 2009-09-10 National Institute Of Advanced Industrial & Technology リポソームおよびそれからなる細胞への物質導入担体
US8410064B2 (en) * 2009-08-24 2013-04-02 The Board Of Trustees Of The University Of Arkansas Classical cannabinoid metabolites and methods of use thereof
US8420118B2 (en) * 2009-09-10 2013-04-16 The Board Of Regents Of The University Of Oklahoma Anionic lipids and lipid nano-structures and methods of producing and using same
US8992897B2 (en) 2010-01-06 2015-03-31 Elc Management Llc Skin lightening compositions
US8722026B2 (en) 2010-01-06 2014-05-13 Elc Management, Llc Skin lightening compositions
JP5894143B2 (ja) 2010-03-22 2016-03-23 リプロス セラピューティクス インコーポレイテッド 抗黄体ホルモンの無毒送達のための組成物および方法
US8883218B2 (en) * 2010-03-26 2014-11-11 The Board Of Trustees Of The University Of Arkansas Anti-cancer nanoparticle compositions and methods of use
US20120237494A1 (en) * 2010-09-30 2012-09-20 Daly Susan M Compositions Containing Zinc PCA And Anogeissus Extract
UA113283C2 (xx) 2010-12-23 2017-01-10 19-норстероїди і їх застосування для лікування прогестеронзалежних станів
US9095598B2 (en) 2010-12-28 2015-08-04 The Board Of Trustees Of The University Of Arkansas Stilbenoid derivatives and their uses
US20120230930A1 (en) * 2011-03-08 2012-09-13 Corstjens Hugo A Methods For Activating Caspase-14 Expression In Human Skin
EP2537513A3 (de) 2011-03-11 2015-04-29 ELC Management LLC Verwendung von Anogeissus-Extrakt zur Fibrillinerzeugung in der Haut
ES2545855T3 (es) 2011-06-09 2015-09-16 Isdin, S. A. Uso de fotoliasa para la reducción o mejora del campo de cancerización subclínico asociado a la queratosis actínica
ES2393338B1 (es) * 2011-06-09 2013-08-19 Isdin, S. A. Uso de fotoliasa para la reducción o mejora del campo de cancerización subclínico asociado a la queratosis actínica.
US20130084326A1 (en) * 2011-10-03 2013-04-04 Bruce Howe Liposomes for the oral delivery of therapeutic agents
KR20170012588A (ko) 2011-10-11 2017-02-02 이엘씨 매니지먼트 엘엘씨 피부를 처리하기 위한 방법 및 조성물
NZ702467A (en) 2012-05-31 2016-07-29 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
US20140066837A1 (en) 2012-07-26 2014-03-06 Ronald L. Moy Skin care compositions and methods
US9365856B2 (en) 2012-09-14 2016-06-14 The Board Of Trustees Of The University Of Arkansas Methods of using a serum response factor isoform
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
CN104797237B (zh) * 2012-09-14 2020-11-24 Elc 管理有限责任公司 用于改善角蛋白表面的细胞中的选择性分解代谢的方法和组合物
CA2888377C (en) 2012-11-02 2021-02-02 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
US8840929B2 (en) 2012-12-11 2014-09-23 Elc Management Llc Cosmetic compositions with near infra-red (NIR) light-emitting material and methods therefor
US9408790B2 (en) 2012-12-11 2016-08-09 Elc Management Llc Cosmetic compositions with near infra-red (NIR) light-emitting material and methods therefor
US8852616B2 (en) 2012-12-11 2014-10-07 Elc Management Llc Cosmetic compositions with near infra-red (NIR) light-emitting material and methods therefor
CN111494253A (zh) 2013-01-07 2020-08-07 Elc 管理有限责任公司 用于改善角蛋白表面的细胞中的选择性分解代谢和活力的方法和组合物
WO2015031645A1 (en) 2013-08-28 2015-03-05 Washington University Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
US9469650B2 (en) 2013-11-08 2016-10-18 Board Of Trustees Of The University Of Arkansas Melampomagnolide B derivatives
US9487536B2 (en) 2013-11-08 2016-11-08 Board Of Trustees Of The University Of Arkansas Melampomagnolide B derivatives
EP3708170A1 (de) 2014-05-05 2020-09-16 BioVentures, LLC Zusammensetzungen und verfahren zur hemmung von antiapoptotischen bcl-2-proteinen als anti-aging mittel
AU2015292710A1 (en) 2014-07-22 2017-02-16 Bioventures, Llc. Compositions and methods for selectively depleting senescent cells
EP3172222A4 (de) 2014-07-24 2018-03-21 Washington University Gegen strahlungsinduzierte moleküle gerichtete zusammensetzungen und verfahren zur verwendung davon
EA036833B1 (ru) 2014-09-10 2020-12-24 Вашингтон Юниверсити Способ лечения предраковых поражений кожи
US10918629B2 (en) 2014-10-20 2021-02-16 The Curators Of The University Of Missouri Method for treating lymphedema
US9981990B2 (en) 2014-12-03 2018-05-29 Bioventures, Llc Melampomagnolide B dimers
US10793613B2 (en) 2014-12-15 2020-10-06 Washington University Compositions and methods for targeted cytokine delivery
JP2018509412A (ja) 2015-03-10 2018-04-05 イーエルシー マネージメント エルエルシー 炎症を収束させるよう皮膚を処置するための方法および組成物ならびに炎症収束経路を刺激する活性物質のスクリーニング
US9545371B2 (en) 2015-03-20 2017-01-17 Elc Management Llc Method of making an optically-activated system
US9962565B2 (en) 2015-03-20 2018-05-08 Elc Management Llc Optically-activated system for reducing the appearance of skin imperfections
US10030022B2 (en) 2015-03-20 2018-07-24 Elc Management Llc Method of stabilizing riboflavin
WO2016187499A1 (en) 2015-05-20 2016-11-24 Syracuse University Improved glycemic control using intrinsic factor bound to a vitamin b12 conjugate of a glucagon-like peptide- 1 receptor agonist
US10716827B2 (en) 2015-05-20 2020-07-21 Syracuse University Compositions and methods for enhancing peptide stability against protease digestion
WO2017011728A1 (en) 2015-07-15 2017-01-19 Washington University ANTIBODIES TO TUMOR ASSOCIATED COMPLEX N-GLYCANS WITH TERMINAL GlcNAcBeta RESIDUES AND METHODS OF USE THEREOF
US9789070B2 (en) 2015-07-28 2017-10-17 Elc Management Llc Sheet packs for treating facial or body surfaces
EP3124609A1 (de) 2015-07-29 2017-02-01 IFOM Fondazione Istituto Firc di Oncologia Molecolare Therapeutische oligonukleotide
ES2781459T3 (es) 2015-07-29 2020-09-02 Ifom Fondazione St Firc Di Oncologia Molecolare Oligonucleótidos terapéuticos
US9833393B2 (en) 2015-09-24 2017-12-05 Elc Management Llc Method and compositions for treating skin
WO2017079429A1 (en) 2015-11-05 2017-05-11 Board Of Trustees Of The University Of Arkansas Hetero-substituted cyclic lactone analogues and uses thereof
US11938193B2 (en) 2016-01-08 2024-03-26 Washington University Compositions comprising chemerin and methods of use thereof
AU2017212653A1 (en) 2016-01-29 2018-07-19 Bioventures, Llc Triazole derivatives of melampomagnolide B and methods of use thereof
US11053293B2 (en) 2016-02-05 2021-07-06 Washington University Compositions and methods for targeted cytokine delivery
ITUA20161994A1 (it) 2016-03-24 2017-09-24 Azienda Ospedaliera Univ Senese Uso degli inibitori ddx3 come agenti anti-iperproliferativi
US10213448B2 (en) 2016-03-25 2019-02-26 Novazoi Theranostics Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof
JP6936498B2 (ja) 2016-04-21 2021-09-15 バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーＢｉｏＶｅｎｔｕｒｅｓ， ＬＬＣ 抗アポトーシス性Ｂｃｌ−２ファミリータンパク質の分解を誘導する化合物及びその使用
US10154955B2 (en) 2016-07-01 2018-12-18 Access Business Group International Llc Compositions including bauhinia, methods of making and using the same in skin anti-aging and other skin applications
WO2018081388A1 (en) 2016-10-26 2018-05-03 Washington University Compositions comprising desaminotyrosine and uses thereof to enhance type i interferon stimulation
US10660419B2 (en) 2016-12-15 2020-05-26 Elc Management Llc Packaged skin treatment composition and method
US11352436B2 (en) 2017-02-10 2022-06-07 Washington University Antibodies to TIP1 and methods of use thereof
US11351227B2 (en) 2017-04-27 2022-06-07 Washington University Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof
US11596655B2 (en) 2017-04-27 2023-03-07 Washington University Activation of natural cytotoxicity receptor 2 (NCR2)
WO2018231690A1 (en) 2017-06-12 2018-12-20 Washington University Zika virus strains for treatment of glioblastoma
US20200165203A1 (en) 2017-07-31 2020-05-28 Washington University Use of pirfenidone and derivatives for modulation of b lymphocyte activity and organ protection from acute tissue damage
WO2019036509A1 (en) 2017-08-14 2019-02-21 Washington University METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH CANCER, INFLAMMATION OR IMMUNE RESPONSE
US11097018B2 (en) 2017-09-06 2021-08-24 Washington University Organomedicinals for imaging and treatment of neurodegenerative disorders
CA3088253A1 (en) 2018-01-22 2019-07-25 Bioventures, Llc Bcl-2 proteins degraders for cancer treatment
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN110559394A (zh) 2018-06-06 2019-12-13 捷通国际有限公司 包含金钗石斛的组合物及其使用方法
US20210300939A1 (en) 2018-07-23 2021-09-30 Signalrx Pharmaceuticals, Inc. Single Molecule Compounds Providing Multi-Target Inhibition of BTK and Other Proteins and Methods of Use Thereof
WO2020055946A1 (en) 2018-09-12 2020-03-19 The Broad Institute, Inc. Targeting egln1 in cancer
CA3127759A1 (en) 2019-01-24 2020-07-30 Council Of Scientific And Industrial Research Kit for detecting melanoma
US11964001B2 (en) 2019-04-09 2024-04-23 Washington University Compositions for treating or preventing respiratory tract infections and method of use thereof
US11752199B1 (en) 2020-02-25 2023-09-12 Mallinckrodt Ard Ip Unlimited Company Methods of modulating pericytes
EP3973978A1 (de) 2020-09-25 2022-03-30 Mallinckrodt Ard IP Unlimited Company Verfahren zur modulation der corticosteroid-reaktion
EP4050002A1 (de) 2021-02-26 2022-08-31 First Health Pharmaceuticals B.V. Antiproliferative wirkstoffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
DK22879A (da) * 1978-01-27 1979-07-28 Sandoz Ag Fremgangsmaade til fremstilling af et medikamentafgivelsessystem
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US5077211A (en) * 1988-07-06 1991-12-31 Applied Genetics, Inc. Purification and administration of dna repair enzymes

Also Published As

Publication number Publication date
AU634970B2 (en) 1993-03-11
DE68917729T2 (de) 1995-04-06
AU3393993A (en) 1993-05-20
US5296231A (en) 1994-03-22
US5077211A (en) 1991-12-31
EP0423214A4 (en) 1991-11-13
JP3328603B2 (ja) 2002-09-30
JPH03505671A (ja) 1991-12-12
JP3292473B2 (ja) 2002-06-17
IL90880A (en) 1995-05-26
EP0423214A1 (de) 1991-04-24
EP0423214B1 (de) 1994-08-24
AU3872489A (en) 1990-02-05
ZA894971B (en) 1990-06-27
AU660767B2 (en) 1995-07-06
WO1990000598A1 (en) 1990-01-25
JPH11346767A (ja) 1999-12-21

Similar Documents

Publication Publication Date Title
DE68917729D1 (de) Reinigung und verabreichung von dns-reparatur-enzymen.
DE68920223T2 (de) Enzymelektroden und ihre Herstellung.
DE3684398D1 (de) Lipolytische enzyme und deren anwendung in reinigungsmitteln.
DE68910713T2 (de) Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.
DE3777565D1 (de) Anordnung von pumpeinheiten und sammelleitung hierfuer.
DE3763813D1 (de) Enzyme enthaltendes reinigungs- und bleichmittel.
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
DE3789880D1 (de) Isolierung und Expression von bei der Biosynthese von Beta-Laktamen beteiligten Genen.
DE3751576D1 (de) Virale Inaktivierung und Reinigung von aktiven Proteinen.
DE59001142D1 (de) Acetale von oxo-tetralinen und von oxo-indanen.
DE3780506T2 (de) Reinigung des einkettigen und zweikettigen gewebeplasminogenaktivators.
DE68919656T2 (de) Enzymhaltige Detergenszusammensetzungen und ihre Verwendung.
DE69012298T2 (de) Heizen von Lagern und dergleichen.
DE3880307D1 (de) Perfluoralkene und fluorierungsprodukte davon.
DE69007121T2 (de) Enzymhaltige flüssige waschmittelzusammensetzungen und deren verwendung.
DE69012958T2 (de) Fibrinolytisches Protein und Herstellungsweise dafür.
DE68905638T2 (de) Herstellung von alkansulfonylhaliden und alkansulfonsaeuren.
DE68918639T2 (de) Färbehilfsmittelzusammensetzung und Färbeverfahren.
DE3852191T2 (de) Polyethylenterephthalat und Verwendungen davon.
DE3784437T2 (de) Spinnloesung und daraus hergestellte artikel.
DE69002234D1 (de) Ultraschallbehandlung von teigerzeugnissen.
DE3875845T2 (de) Neues hypoglykaemisches und wachstum anregendes mittel.
LV5812A4 (lv) Polipeptida iegusanas panemiens ekspresijas vektors un dns secibas
ATE100492T1 (de) Proteolytische enzyme und ihre verwendung in waschmitteln.
ATE95235T1 (de) Modulare einheit von antikoerpergenen, daraus hergestellte antikoerper und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition